AU511714B2 - 1,3-dithiolan-2-yl(1,3-dithian-2-yl) alicylamine derivatives - Google Patents

1,3-dithiolan-2-yl(1,3-dithian-2-yl) alicylamine derivatives

Info

Publication number
AU511714B2
AU511714B2 AU32242/78A AU3224278A AU511714B2 AU 511714 B2 AU511714 B2 AU 511714B2 AU 32242/78 A AU32242/78 A AU 32242/78A AU 3224278 A AU3224278 A AU 3224278A AU 511714 B2 AU511714 B2 AU 511714B2
Authority
AU
Australia
Prior art keywords
alicylamine
dithiolan
dithian
derivatives
alicylamine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU32242/78A
Other languages
English (en)
Other versions
AU3224278A (en
Inventor
H Ramuz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU3224278A publication Critical patent/AU3224278A/en
Application granted granted Critical
Publication of AU511714B2 publication Critical patent/AU511714B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU32242/78A 1973-12-21 1978-01-06 1,3-dithiolan-2-yl(1,3-dithian-2-yl) alicylamine derivatives Expired AU511714B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds
CHCH18,030/7 1973-12-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU76,008/74 Division 1978-01-06

Publications (2)

Publication Number Publication Date
AU3224278A AU3224278A (en) 1978-05-25
AU511714B2 true AU511714B2 (en) 1980-09-04

Family

ID=4429892

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32242/78A Expired AU511714B2 (en) 1973-12-21 1978-01-06 1,3-dithiolan-2-yl(1,3-dithian-2-yl) alicylamine derivatives

Country Status (24)

Country Link
JP (1) JPS595594B2 (fr)
AT (5) AT344693B (fr)
AU (1) AU511714B2 (fr)
BE (1) BE823625A (fr)
CA (4) CA1057295A (fr)
CH (3) CH611614A5 (fr)
DD (1) DD116829A5 (fr)
DE (2) DE2460593C3 (fr)
DK (1) DK148323C (fr)
ES (5) ES433172A1 (fr)
FI (1) FI67216C (fr)
FR (1) FR2255064B1 (fr)
GB (3) GB1489086A (fr)
HK (1) HK43380A (fr)
HU (1) HU170429B (fr)
IE (1) IE40788B1 (fr)
IL (3) IL46146A (fr)
LU (1) LU71530A1 (fr)
NL (1) NL158496B (fr)
NO (1) NO142669C (fr)
PH (3) PH19393A (fr)
SE (2) SE415763B (fr)
YU (1) YU39311B (fr)
ZA (1) ZA747526B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (fr) * 1981-10-28 1983-04-29 Delalande Sa Nouveaux derives du benzaldehyde 3-4-diethere et leur procede de preparation
JPS60142297U (ja) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 フオ−クリフトにおける旋回型運転席の回転装置
JPS62171328U (fr) * 1986-04-23 1987-10-30
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
AU2002367425B2 (en) * 2001-12-28 2006-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
US20100137403A1 (en) * 2008-07-10 2010-06-03 Scott Malstrom Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
LU71530A1 (fr) 1976-11-11
AT349014B (de) 1979-03-12
GB1489086A (en) 1977-10-19
SE415763B (sv) 1980-10-27
HK43380A (en) 1980-08-22
NO142669B (no) 1980-06-16
ATA39178A (de) 1978-08-15
DK668174A (fr) 1975-08-25
AT350053B (de) 1979-05-10
ES451134A1 (es) 1977-08-16
DE2463173C2 (de) 1987-01-29
FI352774A (fr) 1975-06-22
ES451136A1 (es) 1977-10-01
IL46146A (en) 1980-09-16
DE2460593C3 (de) 1979-09-13
IL52844A0 (en) 1977-10-31
DE2460593B2 (de) 1979-01-18
IL52843A0 (en) 1977-10-31
YU336874A (en) 1982-05-31
HU170429B (fr) 1977-06-28
NL7416507A (nl) 1975-06-24
DK148323C (da) 1986-03-03
CH620920A5 (en) 1980-12-31
BE823625A (fr) 1975-06-20
JPS595594B2 (ja) 1984-02-06
SE434746B (sv) 1984-08-13
PH13326A (en) 1980-03-13
CA1079290A (fr) 1980-06-10
CH620921A5 (en) 1980-12-31
AU3224278A (en) 1978-05-25
CA1086320A (fr) 1980-09-23
FR2255064A1 (fr) 1975-07-18
FI67216C (fi) 1985-02-11
ES451137A1 (es) 1977-08-16
ES451135A1 (es) 1977-08-16
JPS5095267A (fr) 1975-07-29
IE40788B1 (en) 1979-08-15
ATA38978A (de) 1978-10-15
CA1072966A (fr) 1980-03-04
FR2255064B1 (fr) 1978-03-24
ZA747526B (en) 1975-12-31
YU39311B (en) 1984-10-31
IE40788L (en) 1975-06-21
GB1489088A (en) 1977-10-19
AT344693B (de) 1978-08-10
PH19393A (en) 1986-04-07
PH13396A (en) 1980-03-28
NO744615L (fr) 1975-07-21
ATA38778A (de) 1978-08-15
FI67216B (fi) 1984-10-31
NL158496B (nl) 1978-11-15
AU7600874A (en) 1976-06-03
DE2460593A1 (de) 1975-07-03
AT349013B (de) 1979-03-12
ATA1022674A (de) 1977-12-15
AT349012B (de) 1979-03-12
NO142669C (no) 1980-09-24
CH611614A5 (en) 1979-06-15
CA1057295A (fr) 1979-06-26
DK148323B (da) 1985-06-10
GB1489087A (en) 1977-10-19
ATA38878A (de) 1978-08-15
SE7416086L (fr) 1975-06-23
IL46146A0 (en) 1975-03-13
DD116829A5 (fr) 1975-12-12
ES433172A1 (es) 1977-04-16

Similar Documents

Publication Publication Date Title
AU468242B2 (en) 2-cyclohexene-1-one derivatives
CA1026760A (fr) Derives de la 3,-4-dihydro-2h-naphtaline-1-un-5-oxypropile-piperazine
AU511714B2 (en) 1,3-dithiolan-2-yl(1,3-dithian-2-yl) alicylamine derivatives
CA1025448A (fr) Derives du benzo-1,3-dioxole
CA1029726A (fr) Derives de naphtyridene-1,8 carboxami-detetrazolyl-3
CA1022169A (en) 4"-0-sulfonyl erythromycin-9-0-oxime derivatives
CA1035359A (fr) Derives de tetrahydro-1,2,3,4 isoquinoline substitues en 1 et disubstitues en 6,7
AU503626B2 (en) Substituted 1, 5-diphenyl-3-formazancarbonitriles
CA1018157A (en) 8,8'-dioxo-6,6'-azopurine
AU490726B2 (en) 1, 3-dithiolan-2-yl alkylamine derivatives
AU507862B2 (en) Novel 2,3-dioxopiperazine derivatives
AU492554B2 (en) 6-alkyl-9,10-dihydro-2' b-methyl-5'-benzyl-ergopeptide derivatives
AU458655B2 (en) Benzenesulfonylurea derivatives
AU477537B2 (en) 3, 4-DIHYDRO-2H-NAPHTHALIN-lone-5-OXYPROPYLPIPERAZINE DERIVATIVES
AU480736B2 (en) 1, 2-diphenyl-ethane derivatives
AU487239B2 (en) 2, 3-methanoprostaglandin derivatives
AU7582674A (en) 6-alkyl-9,10-dihydro-2' b-methyl-5'-benzyl-ergopeptide derivatives
AU482390B2 (en) New derivatives of 2,benzamido-5-nitro-thiazoles
AU6650674A (en) 1, 2-diphenyl-ethane derivatives
AU489429B2 (en) Novel 1,4-dihydropyridine derivatives
AU7135574A (en) New derivatives of 2,benzamido-5-nitro-thiazoles
CA992960A (en) 2,2'-anhydro-b-d-arabinofuranosyl-5-fluorocytosine
AU482770B2 (en) 4-deoxy-4-oxoerythromycin b derivatives
AU483899B2 (en) 7- methoxycephalosporin derivatives
AU470521B2 (en) 5-benzyl-pyrimidine derivatives